10-Q: Quarterly report
Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8
Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment
Clene Announces Significant Positive Results From LTE VISIONARY-MS Trial
NASDAQ TRADE HALT CLNNW.O HALT NEWS PENDING AT 06:55 AM
NASDAQ TRADE HALT CLNNW.O HALT NEWS PENDING AT 06:55 AM
No Data